Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.7 USD | -1.25% | -0.09% | -50.81% |
Business Summary
Number of employees: 487
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Medicines
100.0
%
| 8 | 100.0 % | 86 | 100.0 % | +1,024.84% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 8 | 100.0 % | 86 | 100.0 % | +1,024.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 30/09/20 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 28/02/13 |
Mike Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/13 |
Laura Gault
CTO | Chief Tech/Sci/R&D Officer | - | 30/10/22 |
Matt Lasmanis
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/20 |
Amy Schacterle
COO | Chief Operating Officer | - | 12/02/15 |
Jeff Jonas
BRD | Director/Board Member | 71 | 13/08/13 |
Tammy J. Phinney
LAW | General Counsel | - | 31/07/20 |
Vanessa Procter
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 20/09/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13/08/13 |
Barry Greene
CEO | Chief Executive Officer | 60 | 30/09/20 |
Jim Frates
BRD | Director/Board Member | 56 | 30/04/14 |
Michael Cola
BRD | Director/Board Member | 64 | 10/09/14 |
Geno Germano
CHM | Chairman | 63 | 18/07/16 |
Director/Board Member | 67 | 22/01/19 | |
Director/Board Member | 61 | 22/01/19 | |
Jessica Federer
BRD | Director/Board Member | - | 14/03/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 60,185,064 | 52,677,105 ( 87.53 %) | 3,033 ( 0.005039 %) | 87.53 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.81% | 652M | |
+16.51% | 122B | |
+19.35% | 115B | |
+21.22% | 26.64B | |
-23.73% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-18.37% | 15.49B | |
+63.72% | 14.83B | |
+1.99% | 13.67B |
- Stock Market
- Equities
- SAGE Stock
- Company Sage Therapeutics, Inc.